دورية أكاديمية

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients.

التفاصيل البيبلوغرافية
العنوان: The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients.
المؤلفون: Chopra VK; Clinical Cardiology Heart Failure and Research, Max Super Speciality Hospital, New Delhi, IND., Mohanan PP; Cardiology, Westfort Hi-Tech Hospital, Thrissur, IND., Kher V; Nephrology, Medanta Kidney and Urology Institute, Gurugram, IND., Mantri RR; Cardiology, Sir Ganga Ram Hospital, New Delhi, IND., Isaacs R; Nephrology, Deep Kidney Care Centre, Ludhiana, IND., Jadhav U; Cardiology, Mahatma Gandhi Mission (MGM) New Bombay Hospital, Navi Mumbai, IND., Zalte N; Medical Affairs, Cipla Ltd., Mumbai, IND., Sugumaran A; Medical Affairs, Cipla Ltd., Mumbai, IND., Mohanasundaram S; Medical Affairs, Cipla Ltd., Mumbai, IND.
المصدر: Cureus [Cureus] 2023 Jul 16; Vol. 15 (7), pp. e41957. Date of Electronic Publication: 2023 Jul 16 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Heart failure is associated with an increased frequency of hospitalization, reduced life span, and greater risk to public health, thus posing a challenge. In India, torsemide is one of the commonly used loop diuretics for decongestion in heart failure. However, this use of torsemide, including its dosing, and up/down titration, is based on practical experience. Loop diuretic therapy for heart failure patients poses several dilemmas due to the lack of robust evidence based on which treatment decisions can be made. To guide physicians on the optimal use of torsemide in heart failure patients with or without renal impairment, a panel of expert cardiologists and nephrologists from India convened to develop this expert opinion document for the use of torsemide. This expert opinion on torsemide will pave the way for optimal management with loop diuretic therapy in real-world heart failure patients.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Chopra et al.)
References: J Cardiovasc Pharmacol. 2009 Jun;53(6):468-73. (PMID: 19430310)
JAMA. 2023 Jan 17;329(3):214-223. (PMID: 36648467)
Indian Heart J. 2018 Jan - Feb;70(1):105-127. (PMID: 29455764)
Am Heart J. 1994 Aug;128(2):352-7. (PMID: 8037103)
Eur J Heart Fail. 2019 Feb;21(2):137-155. (PMID: 30600580)
Natl Med J India. 2010 Sep-Oct;23(5):283-8. (PMID: 21250584)
Am J Med. 2001 Nov;111(7):513-20. (PMID: 11705426)
J Cardiovasc Pharmacol. 2009 Jun;53(6):435-7. (PMID: 19430308)
Heart Fail Rev. 2019 Jul;24(4):461-472. (PMID: 30874955)
JACC Heart Fail. 2018 Apr;6(4):273-285. (PMID: 29226815)
J Am Coll Cardiol. 2007 Aug 28;50(9):859-67. (PMID: 17719472)
Eur Heart J. 2022 Feb 10;43(6):440-441. (PMID: 34922348)
Cardiol J. 2019;26(6):661-668. (PMID: 31909470)
Eur J Heart Fail. 2003 Dec;5(6):793-801. (PMID: 14675858)
Am J Cardiol. 2016 Feb 1;117(3):404-11. (PMID: 26704029)
Eur J Clin Pharmacol. 1986;31 Suppl:35-42. (PMID: 3780838)
Curr Heart Fail Rep. 2017 Oct;14(5):385-392. (PMID: 28785969)
J Am Coll Cardiol. 2004 Jun 2;43(11):2028-35. (PMID: 15172408)
Sci Rep. 2022 Feb 8;12(1):2127. (PMID: 35136147)
Drugs. 1991 Jan;41(1):81-103. (PMID: 1706990)
Eur J Heart Fail. 2002 Aug;4(4):507-13. (PMID: 12167392)
Indian Heart J. 2016 Apr;68 Suppl 1:S61-8. (PMID: 27056656)
Circ Heart Fail. 2009 Jan;2(1):56-62. (PMID: 19750134)
J Card Fail. 2022 May;28(5):e1-e167. (PMID: 35378257)
فهرسة مساهمة: Keywords: expert opinion; heart failure; loop diuretics; optimal management; torsemide
تواريخ الأحداث: Date Created: 20230817 Latest Revision: 20230818
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10426810
DOI: 10.7759/cureus.41957
PMID: 37588313
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.41957